Skip to main content

Table 3 Proportion of patient eligible for MR-HIFU treatment

From: Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer

Inclusion criteria Proportion (%)
Tumour ≤ 3 cm 78.6
No lymph node metastasis 65.0
No lobular subtype 90.2
No EIC 84.6
No previous surgery 91.3
No renal insufficiency 97.3
Not multifocal 82.0
No BRCA mutation 97.4
Tumour reachable 66.3
Distance to skin ≥ 1 cm 65.0
Eligible patientsa 11.9
  1. EIC extensive intraductal component
  2. ai.e. all of the inclusion criteria present